Anti-Aging Skin Stack
83
synergy
3
5,800
intermediate
May 17, 2026
Overview
The Anti-Aging Skin Stack combines the three most evidence-backed peptides for skin aging and longevity into a comprehensive protocol that targets collagen synthesis, cellular aging, and GH-driven tissue regeneration simultaneously. GHK-Cu (glycyl-L-histidyl-L-lysine copper) is the anchor of this stack. As a copper-binding tripeptide that naturally declines with age (from ~200ng/mL at age 20 to ~80ng/mL at 60), GHK-Cu activates over 4,000 human genes — more than any other known compound. For skin, it promotes collagen and elastin synthesis, activates fibroblasts, reduces inflammation, and protects against UV damage. Both topical and injectable forms have peer-reviewed human data supporting skin quality improvements. Epithalon works at the cellular aging level. By activating telomerase and regulating the pineal gland''s circadian signaling, it slows two fundamental mechanisms of skin aging: telomere shortening (which drives cellular senescence) and circadian rhythm disruption (which impairs the nighttime skin repair cycle). Epithalon is used in 10-day courses rather than continuously. CJC-1295 provides the GH axis component. GH decline is one of the primary drivers of skin thinning, reduced collagen density, and decreased healing capacity with age. By amplifying nocturnal GH pulses, CJC-1295 increases IGF-1-driven collagen production throughout the body, including skin. The combination of GHK-Cu (direct collagen synthesis) and CJC-1295 (hormonal collagen support) creates a more sustained and comprehensive collagen protection effect.
Dosing Protocol
GHK-Cu
Every day· subcutaneous or topical
500 mcg
per dose
Epithalon
daily (10-day course)· subcutaneous
5,000 mcg
per dose
CJC-1295
daily (before bed)· subcutaneous
300 mcg
per dose
Goals & Evidence
Disclaimer: This stack is community-submitted and for research purposes only. PeptideVault does not verify the safety or efficacy of submitted stacks. Always consult a qualified healthcare professional before using any peptide protocol.